Opportunities to Partner With Salix

As one of the world’s largest specialty pharmaceutical companies, we are constantly searching for additional licensing and partnership opportunities within the field of gastroenterology. This aligns with our commitment to keep moving gastrointestinal treatment forward for our patients, healthcare professionals, and peers.

One of our strategies is to in-license phase 2, phase 3, or marketed proprietary therapeutic drugs; complete any development requirements; and submit these products for US Food and Drug Administration approval. Once approved, we may market and sell the new products through our specialty sales forces. Much of our growth is driven by our strategic partnerships. We invite you to browse our site and contact us to learn more about partnership opportunities.

To learn more, contact